Michigan Heart, PC

Ypsilanti, Michigan 48197

1 studies enrolling now · 14 studies all time

What they study most

Acute Coronary Syndrome, Acute Myocardial Infarction, Arterial Occlusive Disease, Atrial Fibrillation, Atrial Flutter, Cardiac Remodeling, Cardiac Sudden Death, Cardiovascular Diseases, Carotid Stenosis, Chest Pain, Coronary Artery Disease, Coronary Disease

Studies at this site

• A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart — Recruiting now
• Hybrid Ablation Plus Medical Therapy for Persistent Atrial Fibrillation — Completed
• EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction) — Completed
• ANTHEM-HFrEF Pivotal Study — Stopped early
• International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) — Completed
• Angio-Seal Evolution Device Registry — Completed
• Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
• Post-Myocardial Infarction Remodeling Prevention Therapy — Completed
• The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events — Withdrawn before enrolling
• Advanced Cardiovascular Imaging Consortium — Completed
• Post-Approval Study of the NexStent Carotid Stent System and the FilterWire EZ Embolic Protection System: SONOMA — Stopped early
• Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1) — Stopped early
• Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure. — Completed
• Localization of CRT According to Echocardiography: LOCATE-Pilot Study — Status unconfirmed